Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action

Recruiting Observational Study
Newly Diagnosed Cancer of the Oropharynx, Oral Cavity, Colon or Liver
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
306 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cancers of the upper aerodigestive tract account for around 4% of all malignant tumours worldwide. Colon and liver cancer are the most common digestive cancers. The epidemiology of liver cancer is changing, and the number of deaths from liver cancer has increased by 25% worldwide (Huang 2022). In France, around 19,000 cancers of the upper aerodigestive tract and 88,000 new cases of digestive cance…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patient : * With newly diagnosed cancer of the oropharynx, oral cavity, colon or liver (at any stage). * For whom first-line treatment has been decided including radiotherapy, chemotherapy, immunotherapy and/or surgery. * Able to follow all study procedures in accordance with t…
Contacts

Vanessa COTTET

0380393487

Vanessa.cottet@u-bourgogne.fr

CONTACT